Healthier Communities
Focus Area | Ambitions and Commitments | |
---|---|---|
Access and Affordability |
CSL’s ambition is to advance equitable access to its medicines and vaccines by designing programs around vulnerable populations and expanding strategic donations. Through extension of existing WFH partnership, by 2030, CSL aims to:
|
|
Patient Experience |
CSL’s ambition is to elevate the Patient Experience in drug development by embedding patient insights and lived experience through patient-informed clinical development programs and formalising diversity plans to include representative populations. CSL’s Goals for 2030:
|
|
Donor Experience |
CSL’s ambition is to create best-in-class donor experience in partnership with donors and communities, by continuously innovating the donation process, supporting donors’ holistic well-being, and investing in the health equity of donor communities. CSL’s initial goal for 2030 is to initiate new programs to promote health awareness resources, ensuring that at least 30% of donors gain access. Furthermore, CSL intends to increase donor satisfaction survey results, utilising a new customer satisfaction methodology to be implemented and baselined in FY25. |
CSL's Community Contributions Framework
Focus Area | Focus Area Description | Alignment with our Values and 2030 Strategy |
---|---|---|
Support for Patient Communities |
|
|
Support for Innovation and Science |
|
|
Support for Local Communities |
|
|
Our approach to community contributions is guided by our Code of Responsible Business Practice and Global Community Contributions Policy. The policy applies to all CSL businesses and employees and is intended to be implemented across the businesses to guide decision-making and management of any form of community contribution, financial or by other means.